5/17
04:05 pm
fbrx
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
Medium
Report
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
5/13
04:05 pm
fbrx
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
Medium
Report
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
5/1
05:39 am
fbrx
Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant [Yahoo! Finance]
Medium
Report
Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant [Yahoo! Finance]
4/8
08:00 am
fbrx
Forte Biosciences, Inc. (NASDAQ: FBRX) was upgraded by analysts at LADENBURG THALM/SH SH from a "neutral" rating to a "buy" rating. They now have a $2.75 price target on the stock.
Medium
Report
Forte Biosciences, Inc. (NASDAQ: FBRX) was upgraded by analysts at LADENBURG THALM/SH SH from a "neutral" rating to a "buy" rating. They now have a $2.75 price target on the stock.
3/18
04:05 pm
fbrx
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
Low
Report
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update